KR

Konappalli Ramachandrappa Ganapathi

Active Director Director DIN 10331441
DIN 10331441 First appointment Sep 2023 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Konappalli Ramachandrappa Ganapathi

Data last updated:

Konappalli Ramachandrappa Ganapathi is a Director at Admed Lifesciences Private Limited (since 2023). The company operates in Pharma.

DIN 10331441
Primary Designation Director
Industry Pharma
First Appointment 22 Sep 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Admed Lifesciences Private Limited U46497KA2023PTC178991
Director22 Sep 20232023Active

Board colleagues of Konappalli Ramachandrappa Ganapathi

Directorship timeline

Open interactive timeline →
Admed Lifesciences Private Limited
Premium access

Shareholding and investment profile for Konappalli Ramachandrappa Ganapathi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Konappalli Ramachandrappa Ganapathi

Konappalli Ramachandrappa Ganapathi currently holds 1 directorship: Admed Lifesciences Private Limited (Director, since 22 Sep 2023).

Konappalli Ramachandrappa Ganapathi was first appointed on 22 Sep 2023 as Director at Admed Lifesciences Private Limited.

The current boards of Konappalli Ramachandrappa Ganapathi's companies include Konapalli Ramachandrappa Venkataravanappa (Admed Lifesciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available